In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma - Concepedia

Concepedia

Publication | Open Access

In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma

DOI Full Paper Access

75

Citations

34

References

2016

Year

Mariam AlHilli, Marc A. Becker, S. John Weroha, Karen S. Flatten, Rachel M. Hurley, Maria I. Harrell, Ann L. Oberg, Matt Maurer, Kieran Hawthorne, Xiaonan Hou,

Gynecologic Oncology

PathologyImmune Checkpoint InhibitorVivo Anti-tumor ActivityTumor TargetingAnti-cancer AgentTumor SuppressorParp Inhibitor NiraparibProficient Ovarian CarcinomaRadiation OncologyMedicineCell BiologyCancer TreatmentTumor BiologyOvarian Cancer

References

	Year	Citations

Page 1

Page 1